Набор от данни:  Актуализация на регистрите на НСЦРЛП към 02.10.2016 г.

одобрен

Приложение 4 на ПЛС актуализация 02.10.2016

Уникален идентификатор:  84597fd4-9e0d-47ac-b82f-571070203cd1

Текуща версия: 1

Показвана версия: 1

Формат: CSV

  • Създаден на: 2016-10-13 14:34:02
  • Създаден от: georgi_sivchev
  • Последна промяна: 2018-10-16 08:34:00
  • Последно променил: migrate_data
записа на страница
Подреди по:
Възходящ ред Низходящ ред

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

Methylprednisolone II-9509/10.08.2004 SOLU-MEDROL, Powder and solvent for solution for injection, 125, mg, Pack: 1 Pfizer Enterprises SARL, Люксембург Pfizer Manufacturing Belgium N.V./S.A., Rijksweg 12 B-2870, Puurs, Belgium 3.19 0.64 3.83 7% 0.22 3.41 0.68 4.09 20% 0.64 4.05 0.81 4.86 Цената се заличава с решение НСР-3242/14.04.2014 КЦ-3173/04.11.2011 06.03.2013 06.03.2013 Заличен 1639
Methylprednisolone II-9511/10.08.2004 SOLU-MEDROL, Powder and solvent for solution for injection, 40, mg, Pack: 1 Pfizer Enterprises SARL, Люксембург Pfizer Manufacturing Belgium N.V./S.A., Rijksweg 12 B-2870, Puurs, Belgium 2.21 0.44 2.65 7% 0.15 2.36 0.47 2.83 20% 0.44 2.8 0.56 3.36 КЦ-3173/04.11.2011 06.03.2013 06.03.2013 Неактивен 2398
Methylprednisolone II-9512/10.08.2004 SOLU-MEDROL, Powder and solvent for solution for injection, 500, mg, Pack: 1 Pfizer Enterprises SARL, Люксембург Pfizer Manufacturing Belgium N.V./S.A., Rijksweg 12 B-2870, Puurs, Belgium 9.72 1.94 11.66 7% 0.68 10.4 2.08 12.48 20% 1.94 12.34 2.47 14.81 КЦ-672/06.03.2009 23.03.2009 23.03.2009 Неактивен 1640
Methylprednisolone II-9511/10.08.2004 SOLU-MEDROL, Powder and solvent for solution for injection, 40, mg, Pack: 1 Pfizer Enterprises SARL, Люксембург Pfizer Manufacturing Belgium N.V./S.A., Rijksweg 12 B-2870, Puurs, Belgium 2.29 0.46 2.75 7% 0.16 2.45 0.49 2.94 20% 0.46 2.91 0.58 3.49 КЦ-672/06.03.2009 23.03.2009 23.03.2009 Неактивен 2398
Methylprednisolone II-9510/10.08.2004 SOLU-MEDROL, Powder and solvent for solution for injection, 250, mg, Pack: 1 Pfizer Enterprises SARL, Люксембург Pfizer Manufacturing Belgium N.V./S.A., Rijksweg 12 B-2870, Puurs, Belgium 6.14 1.23 7.37 7% 0.43 6.57 1.31 7.88 20% 1.23 7.8 1.56 9.36 КЦ-672/06.03.2009 23.03.2009 23.03.2009 Неактивен 2835
Methylprednisolone II-9509/10.08.2004 SOLU-MEDROL, Powder and solvent for solution for injection, 125, mg, Pack: 1 Pfizer Enterprises SARL, Люксембург Pfizer Manufacturing Belgium N.V./S.A., Rijksweg 12 B-2870, Puurs, Belgium 3.29 0.66 3.95 7% 0.23 3.52 0.7 4.22 20% 0.66 4.18 0.84 5.02 КЦ-672/06.03.2009 23.03.2009 23.03.2009 Неактивен 1639
Somatostatin II-14278/27.09.2006 SOMATOSTATIN LYOMARK 3, Powder and solvent for solution for injection, 3, mg, Pack: 5 Lyomark Pharma GmbH, Германия Wasserburger Arzneimittelwerk GmbH, Germany 567.19 113.44 680.63 4% 10 577.19 115.44 692.63 16% 25 602.19 120.44 722.63 КЦ-1152/07.10.2009 29.10.2009 29.10.2009 Активен 832
Somatostatin II-14278/27.09.2006 SOMATOSTATIN LYOMARK 3, Powder and solvent for solution for injection, 3, mg, Pack: 1 Lyomark Pharma GmbH, Германия Wasserburger Arzneimittelwerk GmbH, Germany 131.04 26.21 157.25 4% 5.24 136.28 27.26 163.54 16% 20.97 157.25 31.45 188.7 КЦ-1152/07.10.2009 29.10.2009 29.10.2009 Активен 831
Somatostatin 20120385 Somatostatin PH&T, Powder and solvent for solution for injection, 3, mg, Pack: 1 флакон + 1 ампула PH & T S.p.A., Италия Alfa Wassermann S.p.A., Италия 93.96 18.79 112.75 4% 3.76 97.72 19.54 117.26 16% 15.03 112.75 22.55 135.3 НСР-4635/15.09.2014 30.09.2014 30.09.2014 Активен 3172
Somatostatin II-0859/15.10.2007 Somatostatin-UCB, Powder and solvent for solution for infusion, 0.25, mg, Pack: 1 UCB Pharma SA, Белгия UCB Pharma SA, Belgium 3.72 0.74 4.46 7% 0.26 3.98 0.8 4.78 20% 0.74 4.72 0.94 5.66 НСР-5738/26.02.2015. 12.03.2015 12.03.2015 Активен 3635
Somatostatin II-0860/15.10.2007 Somatostatin-UCB, Powder and solvent for solution for infusion, 3, mg, Pack: 1 UCB Pharma SA, Белгия UCB Pharma SA, Belgium 44.53 8.91 53.44 4% 1.78 46.31 9.26 55.57 16% 7.12 53.43 10.69 64.12 КЦРР-1205/13.08.2012 г 28.12.2012 28.12.2012 Активен 1498
Somatostatin II-0859/15.10.2007 Somatostatin-UCB, Powder and solvent for solution for infusion, 0.25, mg, Pack: 1 UCB Pharma SA, Белгия UCB Pharma SA, Belgium 3.91 0.78 4.69 7% 0.27 4.18 0.84 5.02 20% 0.78 4.96 0.99 5.95 КЦРР-1205/13.08.2012 г 28.12.2012 28.12.2012 Неактивен 3635
Somatostatin II-0860/15.10.2007 Somatostatin-UCB, Powder and solvent for solution for infusion, 3, mg, Pack: 1 UCB Pharma SA, Белгия UCB Pharma SA, Belgium 89.58 17.92 107.5 4% 3.58 93.16 18.63 111.79 16% 14.33 107.49 21.5 128.99 КЦ-673/06.03.2009 24.03.2009 24.03.2009 Неактивен 1498
Somatostatin II-0859/15.10.2007 Somatostatin-UCB, Powder and solvent for solution for infusion, 0.25, mg, Pack: 1 UCB Pharma SA, Белгия UCB Pharma SA, Belgium 18.66 3.73 22.39 6% 1.12 19.78 3.96 23.74 18% 3.36 23.14 4.63 27.77 КЦ-673/06.03.2009 24.03.2009 24.03.2009 Неактивен 3635
Pegvisomant EU/1/02/240/003 Somavert, Powder for solution for injection, 20, mg, Pack: 30 Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 6919.96 1383.99 8303.95 4% 10 6929.96 1385.99 8315.95 16% 25 6954.96 1390.99 8345.95 цената се заличава КЦРР-2538/14.03.2013 КЦ-3163/04.11.2011 06.03.2013 06.03.2013 Заличен 1643
Pegvisomant EU/1/02/240/003 Somavert, Powder for solution for injection, 20, mg, Pack: 30 Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 7132.23 1426.45 8558.68 4% 10 7142.23 1428.45 8570.68 16% 25 7167.23 1433.45 8600.68 изготвено корекционно решение КЦ-670/06.03.2009 КЦ-575/23.02.2009 10.03.2009 10.03.2009 Неактивен 1643
Pegvisomant EU/1/02/240/002 Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 15 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 4880.58 976.12 5856.7 4% 10 4890.58 978.12 5868.7 16% 25 4915.58 983.12 5898.7 НСР-8982/14.04.2016. 30.04.2016 30.04.2016 Активен 3301
Pegvisomant EU/1/02/240/002 Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 15 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 4902.09 980.42 5882.51 4% 10 4912.09 982.42 5894.51 16% 25 4937.09 987.42 5924.51 Прот. № 136/16.09.2015 НСР-6850/30.07.2015 14.08.2015 14.08.2015 Неактивен 3301
Pegvisomant EU/1/02/240/002 Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 15 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 5062.69 1012.54 6075.23 4% 10 5072.69 1014.54 6087.23 16% 25 5097.69 1019.54 6117.23 НСР-4867/17.10.2014 03.11.2014 03.11.2014 Неактивен 3301
Pegvisomant EU/1/02/240/002 Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 15 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 5121.16 1024.23 6145.39 4% 10 5131.16 1026.23 6157.39 16% 25 5156.16 1031.23 6187.39 НСР-2338/13.01.2014 28.01.2014 28.01.2014 Неактивен 3301
Pegvisomant EU/1/02/240/002 Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 15 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 5265.64 1053.13 6318.77 4% 10 5275.64 1055.13 6330.77 16% 25 5300.64 1060.13 6360.77 КЦ-3163/04.11.2011 06.03.2013 06.03.2013 Неактивен 3301
Pegvisomant EU/1/02/240/002 Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 15 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 5349.2 1069.84 6419.04 4% 10 5359.2 1071.84 6431.04 16% 25 5384.2 1076.84 6461.04 КЦ-575/23.02.2009 10.03.2009 10.03.2009 Неактивен 3301
Pegvisomant EU/1/02/240/001 Somavert, Powder and solvent for solution for injection, 10, mg, Pack: 10 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 3251.12 650.22 3901.34 4% 10 3261.12 652.22 3913.34 16% 25 3286.12 657.22 3943.34 НСР-8981/14.04.2016. 30.04.2016 30.04.2016 Активен 3300
Pegvisomant EU/1/02/240/001 Somavert, Powder and solvent for solution for injection, 10, mg, Pack: 10 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 3266.02 653.2 3919.22 4% 10 3276.02 655.2 3931.22 16% 25 3301.02 660.2 3961.22 Прот. № 136/16.09.2015 НСР-6849/30.07.2015 14.08.2015 14.08.2015 Неактивен 3300
Pegvisomant EU/1/02/240/001 Somavert, Powder and solvent for solution for injection, 10, mg, Pack: 10 mg powder x 30 vials + 8 ml solvent x 30 vials Pfizer Limited, Обединено Кралство Pfizer Manufacturing Belgium NV, Belgium 3383.76 676.75 4060.51 4% 10 3393.76 678.75 4072.51 16% 25 3418.76 683.75 4102.51 НСР-4868/17.10.2014 03.11.2014 03.11.2014 Неактивен 3300
Показва 7825 до 7849 от общо 9712 записа
Линк за сваляне в CSV формат: Копирай
Линк за сваляне в JSON формат: Копирай
Линк за сваляне в XML формат: Копирай
 

Моля изчакайте